18349764. PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION simplified abstract (Arizona Board of Regents on Behalf of Arizona State University)
Contents
- 1 PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION
Organization Name
Arizona Board of Regents on Behalf of Arizona State University
Inventor(s)
Kevin Redding of Tempe AZ (US)
Andrey Kanygin of Phoenix AZ (US)
PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION - A simplified explanation of the abstract
This abstract first appeared for US patent application 18349764 titled 'PHOTOSYSTEM I-BACTERIAL HYDROGENASE CHIMERAS FOR HYDROGEN PRODUCTION
Simplified Explanation
The patent application describes engineered cells for increased hydrogen production, specifically genetically engineered cells containing a fusion protein of a photosystem I (PSI) protein and a bacterial hydrogenase.
- Genetically engineered cells with a fusion protein of PSI protein and bacterial hydrogenase
- Methods for producing genetically engineered cells
- Methods for increasing hydrogen production in cells
Potential Applications
The technology could be applied in the following areas:
- Renewable energy production
- Biotechnology for sustainable fuel sources
Problems Solved
The technology addresses the following issues:
- Low efficiency of hydrogen production
- Environmental impact of traditional fuel sources
Benefits
The technology offers the following benefits:
- Increased hydrogen production
- Reduced environmental impact
- Enhanced sustainability of fuel sources
Potential Commercial Applications
The technology could be utilized in various commercial sectors, such as:
- Energy production
- Biopharmaceuticals
Possible Prior Art
One possible prior art could be the use of genetically engineered cells for biofuel production. However, the specific fusion protein of PSI protein and bacterial hydrogenase described in this patent application may be novel.
Unanswered Questions
How does the fusion protein affect hydrogen production efficiency?
The patent application mentions the fusion protein of PSI protein and bacterial hydrogenase, but it does not delve into the specific mechanisms by which this fusion protein enhances hydrogen production. Further research may be needed to understand the underlying processes.
What are the scalability and cost implications of this technology?
While the patent application outlines the methods for producing genetically engineered cells for increased hydrogen production, it does not discuss the scalability or cost implications of implementing this technology on a larger scale. Understanding these factors is crucial for assessing the commercial viability of the innovation.
Original Abstract Submitted
Provided herein, in some embodiments, are engineered cells and use of the same for increased hydrogen production. In particular, provided herein are genetically engineered cells comprising a polynucleotide encoding a fusion protein comprising a photosystem I (PSI) protein and a bacterial hydrogenase, as well as methods for producing such genetically engineered cells. Also provided herein are methods for increasing hydrogen (H) production in cells.
